Thursday, August 16, 2018
Tags Drug trials

Tag: drug trials

Eisai/Biogen to Advance Alzheimer’s Drug, Provide Fresh Hope

By Julie Steenhuysen and Deena Beasley (Reuters) Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401,...

Special Report: Biotech Incubator Taps Investors through In-House Brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman NEW YORK (Reuters) Last August, National Securities Corp analyst Jonathan Aschoff was bullish on Avenue...

Biogen/Eisai Alzheimer’s Drug Cuts Cognitive Decline 30 Percent: Study

By Julie Steenhuysen CHICAGO (Reuters) Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced...

Bill Gates Backs $30 Million Push for Early Alzheimer’s Diagnostics

CHICAGO (Reuters) Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years...

Zogenix’s Seizure Drug Clears Late-Stage Trial, Shares Soar

By Manas Mishra (Reuters) Zogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second...

Lilly’s Jardiance Meets Main Goal of Two Diabetes Trials

(Reuters) Eli Lilly & Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing...
banner